Corrigendum to “Attenuation of endoplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis induced by isoproterenol” [Experimental and Molecular Pathology Volume 92, Issue 1, February 2012, Pages 97-104](S0014480011001870)(10.1016/j.yexmp.2011.10.012);Attenuation of endoplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis induced by isoproterenol

Experimental and Molecular Pathology

Volumn 92, Issue 1, 2012, Pages 97-104

  Ayala, Pedro ^a   Montenegro, José ^a   Vivar, Raúl ^a   Letelier, Alan ^a   Urroz, Pablo Aránguiz ^a   Copaja, Miguel ^a   Pivet, Deisy ^a   Humeres, Claudio ^a   Troncoso, Rodrigo ^a   Vicencio, José Miguel ^a   Lavandero, Sergio ^a,b   Díaz Araya, Guillermo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

4 Phenylbutyric acid; Endoplasmic reticulum stress; Fibrosis; Heart; Isoproterenol

Indexed keywords

4 PHENYLBUTYRIC ACID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; ISOPRENALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CELL ISOLATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX; GRANULATION TISSUE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84857580547     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2021.104669     Document Type: Erratum

References (49)

1. Azfer A., Niu J., Rogers L.M., Adamski F.M., Kolattukudy P.E. Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. The American Journal of Physiology 2006, 291:H1411-H1420.
2. Barnes J.A., Smoak I.W. Glucose-regulated protein 78 (GRP78) is elevated in embryonic mouse heart and induced following hypoglycemic stress. Anatomy and Embryology 2000, 202:67-74.
3. Becker L.B., vanden Hoek T.L., Shao Z.H., Li C.Q., Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. The American Journal of Physiology 1999, 277:H2240-H2246.
4. Belmont P.J., Chen W.J., San Pedro M.N., Thuerauf D.J., Gellings Lowe N., Gude N., Hilton B., Wolkowicz R., Sussman M.A., Glembotski C.C. Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the ischemic heart. Circulation Research 2010, 106:307-316.
5. Benjamin I.J., Jalil J.E., Tan L.B., Cho K., Weber K.T., Clark W.A. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circulation Research 1989, 65:657-670.
6. Brodsky J.L. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). The Biochemical Journal 2007, 404:353-363.
7. Chagoya de Sánchez V., Hernández-Muñoz R., López-Barrera F., Yañez L., Vidrio S., Suárez J., Cota-Garza M.D., Aranda-Fraustro A., Cruz D. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Canadian Journal of Physiology and Pharmacology 1997, 75:1300-1311.
8. Daosukho C., Chen Y., Noel T., Sompol P., Nithipongvanitch R., Velez J.M., Oberley T.D., St Clair D.K. Phenylbutyrate, a histone deacetylase inhibitor, protects against adriamycin-induced cardiac injury. Free Radical Biology & Medicine 2007, 15:1818-1825.
9. de Almeida S.F., Picarote G., Fleming J.V., Carmo-Fonseca M., Azevedo J.E., de Sousa M. Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. The Journal of Biological Chemistry 2007, 282:27905-27912.
10. Díaz-Muñoz M., Alvarez-Pérez M.A., Yáñez L., Vidrio S., Martínez L., Rosas G., Yáñez M., Ramírez S., de Sánchez V.C. Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction. Molecular and Cellular Biochemistry 2006, 289:125-136.
11. Dover G.J., Brusilow S., Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 1994, 84:339-343.
12. Feng W., Li W. The study of ISO induced heart failure rat model. Experimental and Molecular Pathology 2010, 88:299-304.
13. Galvez A.S., Fiedler J.L., Ocaranza M.P., Jalil J.E., Lavandero S., Diaz-Araya G. Perindopril regulates beta-agonist-induced cardiac apoptosis. Journal of Cardiovascular Pharmacology 2005, 46:255-261.
14. Glembotski C.C. The role of the unfolded protein response in the heart. Journal of Molecular and Cellular Cardiology 2008, 44:453-459.
15. Goh M., Chen F., Paulsen M.T., Yeager A.M., Dyer E.S., Ljungman M. Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells. Neoplasia 2001, 3:331-338.
16. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., Muders F., Riegger G.A., Kromer E.P. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovascular Research 1998, 37:91-100.
17. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
18. Iyer A., Fenning A., Lim J., Le G.T., Reid R.C., Halili M.A., Fairlie D.P., Brown L. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. British Journal of Pharmacology 2010, 159:1408-1417.
19. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes & Development 1999, 13:1211-1233.
20. Kim D.S., Ha K.C., Kwon D.Y., Kim M.S., Kim H.R., Chae S.W., Chae H.J. Kaempferol protects ischemia/reperfusion-induced cardiac damage through the regulation of endoplasmic reticulum stress. Immunopharmacology and Immunotoxicology 2008, 30:257-270.
21. Lamande S.R., Bateman J.F. Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. Seminars in Cell & Developmental Biology 1999, 10:455-464.
22. Liu X.H., Zhang Z.Y., Sun S., Wu X.D. Ischemic postconditioning protects myocardium from ischemia/reperfusion injury through attenuating endoplasmic reticulum stress. Shock 2008, 30:422-427.
23. Luo Z.F., Feng B., Mu J., Qi W., Zeng W., Guo Y.H., Pang Q., Ye Z.L., Liu L., Yuan F.H. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicology and Applied Pharmacology 2010, 246:49-57.
24. Maattanen P., Gehring K., Bergeron J.J., Thomas D.Y. Protein quality control in the ER: the recognition of misfolded proteins. Seminars in Cell & Developmental Biology 2010, 21:500-511.
25. Maestri N.E., Brusilow S.W., Clissold D.B., Bassett S.S. Long-term treatment of girls with ornithine transcarbamylase deficiency. The New England Journal of Medicine 1996, 335:855-859.
26. Mao C., Tai W.C., Bai Y., Poizat C., Lee A.S. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. The Journal of Biological Chemistry 2006, 281:8877-8887.
27. Martindale J.J., Fernandez R., Thuerauf D., Whittaker R., Gude N., Sussman M.A., Glembotski C.C. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circulation Research 2006, 98:1186-1193.
28. Nickson P., Toth A., Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovascular Research 2007, 73:48-56.
29. Okada K., Minamino T., Tsukamoto Y., Liao Y., Tsukamoto O., Takashima S., Hirata A., Fujita M., Nagamachi Y., Nakatani T., Yutani C., Ozawa K., Ogawa S., Tomoike H., Hori M., Kitakaze M. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 2004, 110:705-712.
30. Oyadomari S., Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 2004, 11:381-389.
31. Oyadomari S., Takeda K., Takiguchi M., Gotoh T., Matsumoto M., Wada I., Akira S., Araki E., Mori M. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10845-10850.
32. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
33. Pang M., Zhuang S. Histone deacetylase: a potential therapeutic target for fibrotic disorders. The Journal of Pharmacology and Experimental Therapeutics 2010, 335:266-272.
34. Patil C., Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Current Opinion in Cell Biology 2001, 13:349-355.
35. Perlmutter D.H. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatric Research 2002, 52:832-836.
36. Qi X., Hosoi T., Okuma Y., Kaneko M., Nomura Y. Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Molecular Pharmacology 2004, 66:899-908.
37. Qi X., Vallentin A., Churchill E., Mochly-Rosen D. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. Journal of Molecular and Cellular Cardiology 2007, 43:420-428.
38. Rishikof D.C., Ricupero D.A., Liu H., Goldstein R.H. Phenylbutyrate decreases type I collagen production in human lung fibroblasts. Journal of Cellular Biochemistry 2004, 91:740-748.
39. Rona G. Catecholamine cardiotoxicity. Journal of Molecular and Cellular Cardiology 1985, 17:291-306.
40. Scarabelli T.M., Gottlieb R.A. Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10years of contributions. Cell Death and Differentiation 2004, 11:S144-S152.
41. Severino A., Campioni M., Straino S., Salloum F.N., Schmidt N., Herbrand U., Frede S., Toietta G., Di Rocco G., Bussani R., Silvestri F., Piro M., Liuzzo G., Biasucci L.M., Mellone P., Feroce F., Capogrossi M., Baldi F., Fandrey J., Ehrmann M., Crea F., Abbate A., Baldi A. Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. Journal of the American College of Cardiology 2007, 50:1029-1037.
42. Shizukuda Y., Buttrick P.M., Geenen D.L., Borczuk A.C., Kitsis R.N., Sonnenblick E.H. Beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. The American Journal of Physiology 1998, 275:H961-H968.
43. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiological Reviews 1999, 79:215-262.
44. Szegezdi E., Duffy A., O'Mahoney M.E., Logue S.E., Mylotte L.A., O'Brien T., Samali A. ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochemical and Biophysical Research Communications 2006, 349:406-1411.
45. Thuerauf D.J., Marcinko M., Gude N., Rubio M., Sussman M.A., Glembotski C.C. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circulation Research 2006, 99:275-282.
46. Toth A., Jeffers J.R., Nickson P., Min J.Y., Morgan J.P., Zambetti G.P., Erhardt P. Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. The American Journal of Physiology 2006, 291:H52-H60.
47. Tsung-Ming L., Mei-Shu L., Nen-Chung C. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. The American Journal of Physiology 2007, 293:H968-H977.
48. Vilatoba M., Eckstein C., Bilbao G., Smyth C.A., Jenkins S., Thompson J.A., Eckhoff D.E., Contreras J.L. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 2005, 138:342-351.
49. Zeitlin P.L., Diener-West M., Rubenstein R.C., Boyle M.P., Lee C.K., Brass-Ernst L. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Molecular Therapy 2002, 6:119-126.